OOIR: Observatory of International Research

Papers

(The H4-Index of Nanomedicine-Nanotechnology Biology and Medicine is 26. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)

Article	Citations
Therapeutic efficacy of cancer vaccine adjuvanted with nanoemulsion loaded with TLR7/8 agonist in lung cancer model	54
Dye labeling for optical imaging biases drug carriers' biodistribution and tumor uptake	52
Engineered photonic near-infrared light activated photothermal theranostic nanovaccine induced targeted remodeling of tumor microenvironment	48
Corrigendum to “A light-up “G-quadruplex nanostring” for label-free and selective detection of miRNA via duplex-specific nuclease mediated tandem rolling circle amplification” [Nanomed.: Nanotechnol.	46
Robust aptamer-targeted CRISPR/Cas9 delivery using mesenchymal stem cell membrane –liposome hybrid: BIRC5 gene knockout against melanoma	46
Therapeutic effects of cationic liposomes on lupus-prone MRL/lpr mice are mediated via inhibition of TLR4-triggered B-cell activation	44
Mitochondrial nanomedicine: Subcellular organelle-specific delivery of molecular medicines	41
A novel bidirectional perfusion-like administered system for NIR-II fluorescence imaging precision diagnosis of bladder cancer	41
Macrophage membrane modified baicalin liposomes improve brain targeting for alleviating cerebral ischemia reperfusion injury	39
Albumin-stabilized layered double hydroxide nanoparticles synergized combination chemotherapy for colorectal cancer treatment	39
Diethyldithiocarbamate copper nanoparticle overcomes resistance in cancer therapy without inhibiting P-glycoprotein	36
Novel combination of bioactive agents in bilayered dermal patches provides superior wound healing	35
Comparative examination of the chemistry and biology of AI-driven gold NPs in Theranostics: New insights into biosensing, bioimaging, genomics, diagnostics, and therapy	34
Delivery of gene editing therapeutics	33
Electrospun electroconductive constructs of aligned fibers for cardiac tissue engineering	33
Intrinsic variability of fluorescence calibrators impacts the assignment of MESF or ERF values to nanoparticles and extracellular vesicles by flow cytometry	31
Tyrosine-modified linear PEIs for highly efficacious and biocompatible siRNA delivery in vitro and in vivo	31
Coatsome-replicon vehicles: Self-replicating RNA vaccines against infectious diseases	31
Preferential uptake of antibody targeted calcium phosphosilicate nanoparticles by metastatic triple negative breast cancer cells in co-cultures of human metastatic breast cancer cells plus bone osteob	30
Chitosan-covered calcium phosphate particles as a drug vehicle for delivery to the eye	30
Targeting prostate cancer with Clostridium perfringens enterotoxin functionalized nanoparticles co-encapsulating imaging cargo enhances magnetic resonance imaging specificity	29
Exploiting the preferential phagocytic uptake of nanoparticle-antigen conjugates for the effective treatment of autoimmunity	27
Poly(lipoic acid)-based nanoparticles as a new therapeutic tool for delivering active molecules	26
Determination of spectroscopy marker of atherosclerotic carotid stenosis using FTIR-ATR combined with machine learning and chemometrics analyses	26
In vitro assessment of nanomedicines' propensity to cause palmar-plantar erythrodysesthesia: A Doxil vs. doxorubicin case study	26

Corrigendum to “A theranostic nanocomposite system based on iron oxide-drug nanocages for targeted magnetic field responsive chemotherapy” [Nanomedicine 14(5) (2018) 1643-1654]